Stay updated on Darolutamide in Addition to ADT Clinical Trial
Sign up to get notified when there's something new on the Darolutamide in Addition to ADT Clinical Trial page.

Latest updates to the Darolutamide in Addition to ADT Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedNew revision tag v3.5.4 was added and the previous v3.5.3 tag was removed in the record history. This reflects a minor backend update to the page without altering study data or content.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page’s displayed software/version revision label was updated from v3.5.0 to v3.5.3, reflecting a site release rather than any change to the underlying trial record.SummaryDifference0.0%

- Check70 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 from the page history.SummaryDifference0.0%

- Check78 days agoChange DetectedFooter revision label updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check85 days agoChange DetectedThe record shows the trial status updated to Completed on 2026-02-27, replacing the previous Active, not recruiting status, and adding new Contacts/Locations, Study Status, and Recruitment Status sections on 2026-02-09.SummaryDifference0.3%

- Check99 days agoChange DetectedThe References section was removed from the study record page, and the list of cited sources is no longer displayed.SummaryDifference0.0%

Stay in the know with updates to Darolutamide in Addition to ADT Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Darolutamide in Addition to ADT Clinical Trial page.